212 related articles for article (PubMed ID: 18278175)
1. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Barberis L; Hirsch E
Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
[TBL] [Abstract][Full Text] [Related]
2. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
Hirsch E; Lembo G; Montrucchio G; Rommel C; Costa C; Barberis L
Thromb Haemost; 2006 Jan; 95(1):29-35. PubMed ID: 16543958
[TBL] [Abstract][Full Text] [Related]
3. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
Oudit GY; Penninger JM
Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
[TBL] [Abstract][Full Text] [Related]
4. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.
Hawkins PT; Stephens LR
Science; 2007 Oct; 318(5847):64-6. PubMed ID: 17916723
[TBL] [Abstract][Full Text] [Related]
5. Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development.
Wee S; Lengauer C; Wiederschain D
Curr Opin Oncol; 2008 Jan; 20(1):77-82. PubMed ID: 18043260
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin.
Barberis L; Pasquali C; Bertschy-Meier D; Cuccurullo A; Costa C; Ambrogio C; Vilbois F; Chiarle R; Wymann M; Altruda F; Rommel C; Hirsch E
Eur J Immunol; 2009 Apr; 39(4):1136-46. PubMed ID: 19291697
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment.
Ferrandi C; Ardissone V; Ferro P; Rückle T; Zaratin P; Ammannati E; Hauben E; Rommel C; Cirillo R
J Pharmacol Exp Ther; 2007 Sep; 322(3):923-30. PubMed ID: 17526805
[TBL] [Abstract][Full Text] [Related]
8. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
[TBL] [Abstract][Full Text] [Related]
9. Regulation of class IA PI3Ks.
Wu H; Yan Y; Backer JM
Biochem Soc Trans; 2007 Apr; 35(Pt 2):242-4. PubMed ID: 17371249
[TBL] [Abstract][Full Text] [Related]
10. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Rommel C; Camps M; Ji H
Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
[TBL] [Abstract][Full Text] [Related]
11. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
[TBL] [Abstract][Full Text] [Related]
12. Taming the PI3K team to hold inflammation and cancer at bay.
Hirsch E; Ciraolo E; Ghigo A; Costa C
Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
[TBL] [Abstract][Full Text] [Related]
13. PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?
Rückle T; Schwarz MK; Rommel C
Nat Rev Drug Discov; 2006 Nov; 5(11):903-18. PubMed ID: 17080027
[TBL] [Abstract][Full Text] [Related]
14. Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma.
Costa C; Barberis L; Ambrogio C; Manazza AD; Patrucco E; Azzolino O; Neilsen PO; Ciraolo E; Altruda F; Prestwich GD; Chiarle R; Wymann M; Ridley A; Hirsch E
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14354-9. PubMed ID: 17720808
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation.
Takeda M; Ito W; Tanabe M; Ueki S; Kihara J; Kato H; Tanigai T; Kayaba H; Sasaki T; Chihara J
Int Arch Allergy Immunol; 2010; 152 Suppl 1():90-5. PubMed ID: 20523070
[TBL] [Abstract][Full Text] [Related]
17. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
Zhao JJ; Roberts TM
Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
[TBL] [Abstract][Full Text] [Related]
18. Identification of the macromolecular complex responsible for PI3Kgamma-dependent regulation of cAMP levels.
Perino A; Ghigo A; Damilano F; Hirsch E
Biochem Soc Trans; 2006 Aug; 34(Pt 4):502-3. PubMed ID: 16856844
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase signalling in the vascular system.
Morello F; Perino A; Hirsch E
Cardiovasc Res; 2009 May; 82(2):261-71. PubMed ID: 19038971
[TBL] [Abstract][Full Text] [Related]
20. PI3K class IB pathway.
Andrews S; Stephens LR; Hawkins PT
Sci STKE; 2007 Oct; 2007(407):cm2. PubMed ID: 17925573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
